{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:31:05Z","timestamp":1760981465272},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[1987,6,1]],"date-time":"1987-06-01T00:00:00Z","timestamp":549504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[1987,6]]},"DOI":"10.1016\/s0014-4835(87)80036-2","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T15:43:13Z","timestamp":1156520593000},"page":"717-730","source":"Crossref","is-referenced-by-count":15,"title":["The utilization of 13C and 31P nuclear magnetic resonance spectroscopy in the study of the sorbitol pathway and aldose reductase inhibition in intact rabbit lenses"],"prefix":"10.1016","volume":"44","author":[{"given":"W.F.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Odom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0014-4835(87)80036-2_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/diabetes.33.6.562","article-title":"Localization of aldose reductase in the human eye","volume":"33","author":"Akagi","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/S0014-4835(87)80036-2_bib2","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0014-4835(82)90045-8","article-title":"Sugar cataracts in vitro: implications of oxidative stress and aldose reductase I","volume":"35","author":"Chand","year":"1982","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-4835(83)90145-8","article-title":"Response of the lens to oxidative-osmotic stress","volume":"37","author":"Cheng","year":"1983","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-4835(85)90007-7","article-title":"Sorbitol\/fructose metabolism in the lens","volume":"40","author":"Cheng","year":"1985","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib5","first-page":"401","article-title":"A biochemical evaluation of a cataract induced in a high-glucose medium","volume":"8","author":"Chylack","year":"1969","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/S0014-4835(87)80036-2_bib6","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0161-6420(79)35364-7","article-title":"Efficacy of alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses","volume":"86","author":"Chylack","year":"1979","journal-title":"Ophthalmology"},{"key":"10.1016\/S0014-4835(87)80036-2_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0161-6420(84)34252-X","article-title":"Mechanisms of senile cataract formation","volume":"91","author":"Chylack","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/S0014-4835(87)80036-2_bib8","first-page":"329","article-title":"Lens aldehyde reductase and dehydrogenase, and their possible involvement in diabetes and cataract formation","volume":"114","author":"Crabbe","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0014-4835(79)90025-3","article-title":"Cortical cataract formation prevented by vitamin E and glutathione","volume":"29","author":"Creighton","year":"1979","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib10","first-page":"313","article-title":"Altering the course of cataracts in diabetic rats","volume":"19","author":"Fukushi","year":"1980","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S0014-4835(87)80036-2_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/science.151.3707.209","article-title":"Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes","volume":"151","author":"Gabbay","year":"1966","journal-title":"Science"},{"key":"10.1016\/S0014-4835(87)80036-2_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00253203","article-title":"Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition","volume":"25","author":"Gillon","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/S0014-4835(87)80036-2_bib13","first-page":"89","article-title":"The intralenticular pH during cataractogenesis in the intact lens as determined by phosphorus-31 nuclear magnetic resonance spectroscopy","author":"Glonek","year":"1981","journal-title":"Invest. Ophthalmol. Vis Sci."},{"key":"10.1016\/S0014-4835(87)80036-2_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2337\/diabetes.32.5.482","article-title":"The effect of an aldose reductase inhibitor (sorbinil) on the level of metabolites in lenses of diabetic rats","volume":"32","author":"Gonz\u00e1lez","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/S0014-4835(87)80036-2_bib15","first-page":"808","article-title":"13C-Nuclear magnetic resonance studies of sugar cataractogenesis in the single, intact rabbit lens","volume":"22","author":"Gonz\u00e1lez","year":"1982","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S0014-4835(87)80036-2_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0014-4835(84)90055-1","article-title":"Altered phosphate metabolism in the intact rabbit lens under high glucose conditions and its prevention by an aldose reductase inhibitor","volume":"39","author":"Gonz\u00e1lez","year":"1984","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2337\/diabetes.33.2.196","article-title":"Direct measurement of polyol pathway activity in the ocular lens","volume":"33","author":"Gonz\u00e1lez","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/S0014-4835(87)80036-2_bib18","first-page":"700","article-title":"Organophosphates of the crystalline lens: a nuclear magnetic resonance spectroscopic study","volume":"21","author":"Greiner","year":"1981","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S0014-4835(87)80036-2_bib19","first-page":"613","article-title":"Dynamic changes in the organophosphate profile of the experimental galactose-induced cataract","volume":"22","author":"Greiner","year":"1982","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S0014-4835(87)80036-2_bib20","first-page":"34","article-title":"The sorbitol pathway as protector of the lens against glucose-generated osmotic stress","author":"Harding","year":"1981","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S0014-4835(87)80036-2_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0009-8981(75)90376-9","article-title":"Sorbitol and other polyols in lens, adipose tissue and urine in diabetes mellitus","volume":"63","author":"Heaf","year":"1975","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/S0014-4835(87)80036-2_bib22","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0140-6736(83)92296-1","article-title":"Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: relief of pain and improved somatic and autonomic nerve function","volume":"i","author":"Jaspan","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/S0014-4835(87)80036-2_bib23","first-page":"357","article-title":"Activators and inhibitors of lens aldose reductase","volume":"10","author":"Jedziniak","year":"1971","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/S0014-4835(87)80036-2_bib24","first-page":"980","article-title":"Differences in the susceptibility of various aldose reductases to inhibition","volume":"19","author":"Kador","year":"1980","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/S0014-4835(87)80036-2_bib25","first-page":"84","article-title":"Aldose reductase inhibitors. In Aldose reductase and complications of diabetes","volume":"101","author":"Kador","year":"1984"},{"key":"10.1016\/S0014-4835(87)80036-2_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0014-4835(84)90022-8","article-title":"The purification and properties of human lens glutathione reductase","volume":"39","author":"Latta","year":"1984","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00282524","article-title":"Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats","volume":"25","author":"Mayer","year":"1983","journal-title":"Diabetologica"},{"key":"10.1016\/S0014-4835(87)80036-2_bib28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-4835(64)80027-0","article-title":"The effect of diabetes on the content of sorbitol, glucose, fructose and inositol in the human lens","volume":"3","author":"Pirie","year":"1964","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000265254","article-title":"Studies on glutathione s-transferase, glutathione peroxidase and glutathione reductase in human normal and cataractous lenses","volume":"15","author":"Rao","year":"1983","journal-title":"Ophthalmic Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib30","first-page":"61","article-title":"Modelling cortical cataractogenesis. III. In vivo effects of vitamin E on cataractogenesis in diabetic rats","volume":"17","author":"Ross","year":"1982","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/S0014-4835(87)80036-2_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0014-4835(84)90045-9","article-title":"Longitudinal (T1) relaxation times of phosphorus metabolites in the bovine and rabbit lens","volume":"39","author":"Schleich","year":"1984","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/jm00369a003","article-title":"N-[[5-trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-N-methylglycine (tolrestat), a potent, orally active aldose reductase inhibitor","volume":"27","author":"Sestanj","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/S0014-4835(87)80036-2_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-4835(82)80019-5","article-title":"Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac","volume":"35","author":"Sharma","year":"1982","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-4835(84)90018-6","article-title":"Pyridine nucleotides in normal and cataractous human lenses","volume":"39","author":"Stewart","year":"1984","journal-title":"Exp. Eye Res."},{"key":"10.1016\/S0014-4835(87)80036-2_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1248\/cpb.31.204","article-title":"Sorbitol pathway in lenses of normal and diabetic rabbits","volume":"31","author":"Tanimoto","year":"1983","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/S0014-4835(87)80036-2_bib36","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/0006-2952(76)90457-3","article-title":"Inhibition of lens aldose reductase by flavonoids\u2014their possible role in the prevention of diabetic cataracts","volume":"25","author":"Varma","year":"1976","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0014-4835(87)80036-2_bib37","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.3088727","article-title":"A carbon-13 nuclear magnetic resonance spectroscopy study of aldose reductase inhibition in intact lenses","volume":"233","author":"Williams","year":"1986","journal-title":"Science"},{"key":"10.1016\/S0014-4835(87)80036-2_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/diabetes.31.9.789","article-title":"The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats","volume":"31","author":"Yue","year":"1982","journal-title":"Diabetes"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483587800362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483587800362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T02:20:48Z","timestamp":1547432448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483587800362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1987,6]]}},"alternative-id":["S0014483587800362"],"URL":"https:\/\/doi.org\/10.1016\/s0014-4835(87)80036-2","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[1987,6]]}}}